NATCO Pharma Limited (NSE:NATCOPHARM)
India flag India · Delayed Price · Currency is INR
864.15
+2.05 (0.24%)
Jun 4, 2025, 9:30 AM IST

NATCO Pharma Statistics

Total Valuation

NATCO Pharma has a market cap or net worth of INR 154.41 billion. The enterprise value is 128.08 billion.

Market Cap 154.41B
Enterprise Value 128.08B

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date May 27, 2025
Ex-Dividend Date Feb 18, 2025

Share Statistics

NATCO Pharma has 179.11 million shares outstanding. The number of shares has decreased by -0.21% in one year.

Current Share Class 179.11M
Shares Outstanding 179.11M
Shares Change (YoY) -0.21%
Shares Change (QoQ) +0.06%
Owned by Insiders (%) 14.06%
Owned by Institutions (%) 17.54%
Float 111.86M

Valuation Ratios

The trailing PE ratio is 8.19 and the forward PE ratio is 12.42.

PE Ratio 8.19
Forward PE 12.42
PS Ratio 3.49
PB Ratio 2.03
P/TBV Ratio 2.10
P/FCF Ratio 11.92
P/OCF Ratio 9.10
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.83, with an EV/FCF ratio of 9.89.

EV / Earnings 6.79
EV / Sales 2.89
EV / EBITDA 5.83
EV / EBIT 6.53
EV / FCF 9.89

Financial Position

The company has a current ratio of 5.59, with a Debt / Equity ratio of 0.04.

Current Ratio 5.59
Quick Ratio 3.97
Debt / Equity 0.04
Debt / EBITDA 0.13
Debt / FCF 0.22
Interest Coverage 82.04

Financial Efficiency

Return on equity (ROE) is 27.97% and return on invested capital (ROIC) is 17.34%.

Return on Equity (ROE) 27.97%
Return on Assets (ROA) 15.78%
Return on Invested Capital (ROIC) 17.34%
Return on Capital Employed (ROCE) 25.51%
Revenue Per Employee 11.03M
Profits Per Employee 4.69M
Employee Count 4,016
Asset Turnover 0.57
Inventory Turnover 0.89

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.66% in the last 52 weeks. The beta is 0.31, so NATCO Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.31
52-Week Price Change -13.66%
50-Day Moving Average 837.11
200-Day Moving Average 1,190.67
Relative Strength Index (RSI) 51.09
Average Volume (20 Days) 752,138

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NATCO Pharma had revenue of INR 44.30 billion and earned 18.85 billion in profits. Earnings per share was 105.26.

Revenue 44.30B
Gross Profit 37.40B
Operating Income 19.61B
Pretax Income 22.91B
Net Income 18.85B
EBITDA 21.96B
EBIT 19.61B
Earnings Per Share (EPS) 105.26
Full Income Statement

Balance Sheet

The company has 24.97 billion in cash and 2.79 billion in debt, giving a net cash position of 22.17 billion or 123.80 per share.

Cash & Cash Equivalents 24.97B
Total Debt 2.79B
Net Cash 22.17B
Net Cash Per Share 123.80
Equity (Book Value) 76.12B
Book Value Per Share 424.69
Working Capital 43.27B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.97 billion and capital expenditures -4.01 billion, giving a free cash flow of 12.96 billion.

Operating Cash Flow 16.97B
Capital Expenditures -4.01B
Free Cash Flow 12.96B
FCF Per Share 72.34
Full Cash Flow Statement

Margins

Gross margin is 84.43%, with operating and profit margins of 44.27% and 42.56%.

Gross Margin 84.43%
Operating Margin 44.27%
Pretax Margin 51.73%
Profit Margin 42.56%
EBITDA Margin 49.58%
EBIT Margin 44.27%
FCF Margin 29.25%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.68%.

Dividend Per Share 6.00
Dividend Yield 0.68%
Dividend Growth (YoY) -36.84%
Years of Dividend Growth n/a
Payout Ratio 5.72%
Buyback Yield 0.21%
Shareholder Yield 0.89%
Earnings Yield 12.21%
FCF Yield 8.39%
Dividend Details

Stock Splits

The last stock split was on November 26, 2015. It was a forward split with a ratio of 5.

Last Split Date Nov 26, 2015
Split Type Forward
Split Ratio 5

Scores

Altman Z-Score n/a
Piotroski F-Score n/a